Pradžia › Židinė alopecija › Florida
Židinė alopecija klinikiniai tyrimai Florida
8 tyrimai dėl Židinė alopecija ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Pediatric Skin Research - Miami /ID# 283281, Miami
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Health Clinical Research, LLC, Cutler Bay
Renkami dalyviai2 fazė
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Pediatric Skin Research, Miami
- Skin Research of South Florida, Miami
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- James A. Haley Veterans' Hospital, Tampa
Renkami dalyviai1 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Skin Research of South Florida, Miami
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Skin Care Research Boca Raton /ID# 258012, Boca Raton
- Skin Care Research - Hollywood /ID# 259210, Hollywood
- GSI Clinical Research, LLC /ID# 259352, Margate
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 12 iki 63 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Pediatric Skin Research, Miami
- D&H Tamarac Research Center, Tamarac
Renkami dalyviai3 fazė
Amžius nuo 6 iki 14 · Visoms lytims · Atnaujinta 2026-04-28 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- D&H Doral Research Center, Doral
- Skin Care Research, Llc - Hollywood, Hollywood
- Ilumina Medical Research Llc, Kissimmee
- ir dar 12
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-01-28 · NCT07133308Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.